Latest Financial Results News

Page 23 of 89
Optiscan Imaging Limited reported a 17.6% revenue decline and a 4.1% increase in net loss for FY25, driven by lower orders and higher R&D spending. The company unveiled two new medical imaging devices as it ramps up commercial efforts.
Ada Torres
Ada Torres
29 Aug 2025
Linius Technologies reported a $5.31 million loss for FY25 as it shifts towards a sales-driven SaaS model, with new leadership and cost-cutting measures aiming to reshape its future.
Sophie Babbage
Sophie Babbage
29 Aug 2025
MPower Group Limited has announced a binding agreement to sell its main renewable energy assets for approximately $19 million, reporting a net loss of $4.1 million for FY2025 largely due to discontinued operations.
Maxwell Dee
Maxwell Dee
29 Aug 2025
Papyrus Australia Ltd reported a sharp increase in losses for FY2025, driven by impairment of its Egyptian investments, while securing new funding and advancing commercialization of its banana fibre technology.
Victor Sage
Victor Sage
29 Aug 2025
Adherium Limited reported a $12.68 million net loss for FY2025 as it pivots towards commercialising its smart inhaler technology in the US, supported by a $4.49 million capital raise.
Ada Torres
Ada Torres
29 Aug 2025
Vinyl Group Ltd reported a striking 190% revenue increase for FY2025 but remains deep in the red with a $15.8 million loss. The company’s recent acquisitions and ongoing audit spotlight a pivotal moment for its future.
Victor Sage
Victor Sage
29 Aug 2025
Vmoto Limited reported a 10.8% revenue decline to $20.8 million in H1 2025 but reduced its net loss slightly to $3 million, buoyed by resilient international sales and a strategic partnership with Uber to electrify delivery fleets across Europe.
Victor Sage
Victor Sage
29 Aug 2025
Paradigm Biopharmaceuticals marked FY25 with the launch of its global Phase 3 trial for its osteoarthritis drug iPPS, backed by strong FDA protocol approval and a $41 million funding facility. The company also broadened its pipeline with the acquisition of Pentacoxib™, targeting early-stage OA.
Ada Torres
Ada Torres
29 Aug 2025
First Graphene Limited reported a 13% reduction in net loss for FY25 alongside steady revenue and expanding commercial demand for its PureGRAPH products.
Maxwell Dee
Maxwell Dee
29 Aug 2025
Rhythm Biosciences has significantly reduced its annual loss by 44%, boosted by a 91% rise in other income, while launching a new wholly owned subsidiary, RHY GeneType Pty Ltd.
Ada Torres
Ada Torres
29 Aug 2025
Victor Group Holdings has sharply reduced its FY25 loss to $275,449 from $3.53 million the prior year, while expanding its fintech presence through strategic stakes in LIT Technology and iRich Finance.
Sophie Babbage
Sophie Babbage
29 Aug 2025
AJ Lucas Group Limited has reported a sharp decline in its financial results for FY2025, with revenue down 8.5% and a net loss soaring to $15 million. The company also recorded a significant drop in EBITDA and profit before interest and tax, signaling tough times ahead.
Maxwell Dee
Maxwell Dee
29 Aug 2025